An antimicrobial self-seal coating for Vascular Access Grafts
Lead Participant:
ESP TECHNOLOGY LIMITED
Abstract
ESP technology Ltd has developed an advanced new materials technology specifically to resolve the serious medical complication of post-needling bleeding from ePTFE vascular access grafts after haemodialysis. Our design concept is relatively simple and provides a logical solution - we employ proprietary fabrication techniques to coat the outside of the graft with a novel, inert and biocompatible, micro-cellular elastomer that reduces leakage from needling sites to negligible levels - yet our technological approach is highly innovative and scientifically sophisticated.
Our company is now seeking additional equity investment to fund the further development and scale-up of our methods and equipment for compatibility with the requirements of volume manufacture to relevant industry and Regulatory standards. A Launchpad grant would make an invaluable contribution to advancing our company significantly closer to the point of readiness for commercialisation of our technology.
Our company is now seeking additional equity investment to fund the further development and scale-up of our methods and equipment for compatibility with the requirements of volume manufacture to relevant industry and Regulatory standards. A Launchpad grant would make an invaluable contribution to advancing our company significantly closer to the point of readiness for commercialisation of our technology.
Lead Participant | Project Cost | Grant Offer |
---|---|---|
  | ||
Participant |
||
ESP TECHNOLOGY LIMITED | ||
VASCULAR FLOW TECHNOLOGIES LIMITED | ||
INNOVATE UK |
People |
ORCID iD |
Dr Chris Underwood (Project Manager) |